Integrated BioPharma, Inc. (INBP)
0.1651
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Integrated BioPharma Enterprise Value : 3.736M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.736M |
| November 12, 2026 | 3.736M |
| November 11, 2026 | 3.736M |
| November 10, 2026 | 3.736M |
| November 09, 2026 | 3.736M |
| November 06, 2026 | 3.736M |
| November 05, 2026 | 4.004M |
| November 04, 2026 | 4.004M |
| November 03, 2026 | 3.736M |
| November 02, 2026 | 3.736M |
| October 30, 2026 | 3.732M |
| October 29, 2026 | 3.732M |
| October 28, 2026 | 3.732M |
| October 27, 2026 | 3.887M |
| October 26, 2026 | 3.887M |
| October 23, 2026 | 4.042M |
| October 22, 2026 | 4.042M |
| October 21, 2026 | 4.042M |
| October 20, 2026 | 4.198M |
| October 19, 2026 | 4.198M |
| October 16, 2026 | 4.198M |
| October 15, 2026 | 4.198M |
| October 14, 2026 | 4.271M |
| October 13, 2026 | 4.271M |
| October 12, 2026 | 4.275M |
| Date | Value |
|---|---|
| October 09, 2026 | 4.477M |
| October 08, 2026 | 4.353M |
| October 07, 2026 | 4.477M |
| October 06, 2026 | 4.353M |
| October 05, 2026 | 3.887M |
| October 02, 2026 | 4.260M |
| October 01, 2026 | 4.260M |
| September 30, 2026 | 3.580M |
| September 29, 2026 | 3.887M |
| September 28, 2026 | 3.887M |
| September 25, 2026 | 4.313M |
| September 24, 2026 | 4.353M |
| September 23, 2026 | 4.353M |
| September 22, 2026 | 4.344M |
| September 21, 2026 | 4.263M |
| September 18, 2026 | 3.626M |
| September 17, 2026 | 4.041M |
| September 16, 2026 | 3.887M |
| September 15, 2026 | 4.136M |
| September 14, 2026 | 3.887M |
| September 11, 2026 | 3.887M |
| September 10, 2026 | 4.198M |
| September 09, 2026 | 4.198M |
| September 08, 2026 | 4.198M |
| September 04, 2026 | 4.198M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medifast, Inc. | -6.806M |
| BioForce Nanosciences Holdings, Inc. | 265.29M |
| Skinvisible, Inc. | 6.832M |
| SkyTech Orion Global Corp. | 2.057M |
| Nevis Brands, Inc. | -- |
Enterprise Value Related Metrics
| Gross Profit Margin (Quarterly) | 0.29% |
| Profit Margin (Quarterly) | -13.94% |
| Earnings Yield | -57.83% |
| Normalized Earnings Yield | -55.41 |